Astrazeneca has cancelled a planned £450m investment in a vaccine manufacturing plant in Merseyside, saying Labour have ...

AstraZeneca will no longer invest 450 million pounds ($558.3 million) at its vaccine manufacturing plant in northern England, ...

Several factors have influenced this decision including the timing and reduction of the final offer compared to the previous government’s proposal' ...

AstraZeneca has dropped its plans to £450m at its vaccine manufacturing plant in Speke, Merseyside, blaming a reduction in ...

In a shock move, AstraZeneca has ditched a plan to invest £450 million ($558 million) in a new vaccine manufacturing plant in ...

The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer of help for the Merseyside ...

AstraZeneca Plc abandoned plans to invest £450 million ($558 million) in a UK vaccine manufacturing plant, following protracted wrangling with the new Labour government over the level of state funding ...

Shares in Amazon ( AMZN) are up nearly 46% over the past year, with the stock hitting a record high closing price of $238.15 ...

The pharma giant blamed the Labour government reducing support as it dramatically torpedoed the development on Merseyside.

AstraZeneca has axed plans to build a £450million vaccine manufacturing plant because of a lack of Government support in the ...

AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.

AstraZeneca (AZN) stock in focus as its partner Daiichi Sankyo (DSNKY) wins EU backing for their jointly developed breast ...